Tibra Equities Europe’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Tibra Equities Europe's AMGN Position: Q4 2019 in Review
Tibra Equities Europe sold out of Amgen (AMGN) in Q4 2019, closing a stake of 19,700 shares — an estimated $3.81M sold.
Tibra Equities Europe first reported a position in AMGN in Q3 2018 and held it in 5 quarters. The position peaked at $9.77M in Q4 2018. 2,107 funds tracked by Wall St. Rank hold AMGN as of Q4 2019.
- Tibra Equities Europe reported no remaining Amgen position as of Q4 2019 after selling out during the quarter.
- Tibra Equities Europe sold 19,700 Amgen shares in Q4 2019, an estimated $3.81M.
- Tibra Equities Europe first reported a position in Amgen in Q3 2018 and held it in 5 quarters.
- Tibra Equities Europe's Amgen position peaked at $9.77M in Q4 2018.
- 2,107 funds tracked by Wall St. Rank held Amgen as of Q4 2019.
Based on Tibra Equities Europe's 13F filing for Q4 2019, filed 14 Feb 2020.